Guinea-pig firms to test interim UK value-based pricing in 2014
This article was originally published in Scrip
Some clarity is finally emerging on how the main UK health technology appraisal body NICE will incorporate ‘value-based pricing’ into its decisions. According to a source close to the ongoing but secretive talks, the first NICE appraisals incorporating VBP will take place in June 2014. It is also likely there will be a 6-month “interim process” designed by NICE during which a few companies will work through the VBP process. This interim system will be in place January 2014, allowing the UK government to keep its pledge to launch a new pricing system by the beginning of next year.
You may also be interested in...
Brazil’s medicines regulator, ANVISA, finally has a new set of rules for the evaluation and marketing authorization of advanced therapy medicines.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.